Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kami Maddocks

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
BMJ (Clinical Research Ed.)|April 21, 2022
Novel treatments in B cell non-Hodgkin's lymphomasYazeed Sawalha, Kami Maddocks
Oncotargets and Therapy|July 2, 2020
Profile of Polatuzumab Vedotin in the Treatment of Patients with Relapsed/Refractory Non-Hodgkin Lymphoma: A Brief Report on the Emerging Clinical DataYazeed Sawalha, Kami Maddocks
Seminars in Oncology|April 5, 2016
Bruton tyrosine kinase inhibition in chronic lymphocytic leukemiaKami Maddocks, Jeffrey A Jones
Current Treatment Options in Oncology|February 1, 2014
Ibrutinib in B-cell LymphomasKami Maddocks, Kristie A Blum
Cancer Treatment and Research|February 7, 2015
Treatment strategies in mantle cell lymphomaKami Maddocks, Kristie A Blum
Current Hematologic Malignancy Reports|September 11, 2016
CD30 and CD30-Targeted Therapies in Hodgkin Lymphoma and Other B cell LymphomasGeetika Bhatt, Kami Maddocks, Beth Christian
The Oncologist|January 17, 2023
Clinical Treatment Guidelines for Tafasitamab Plus Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell LymphomaAdrienne Nedved, Kami Maddocks, Grzegorz S Nowakowski
Clinical Advances in Hematology & Oncology : H&O|June 13, 2019
Bruton tyrosine kinase inhibitors for the treatment of mantle cell lymphoma: review of current evidence and future directionsDavid A Bond, Lapo Alinari, Kami Maddocks
Psychology & Health|March 17, 2016
The relation of illness perceptions to stress, depression, and fatigue in patients with chronic lymphocytic leukaemiaTravis D Westbrook, Kami Maddocks, Barbara L Andersen
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|March 26, 2021
Incorporating Novel Targeted and Immunotherapeutic Agents in Treatment of B-Cell LymphomasHarsh Shah, Deborah Stephens, John Seymour, et al.
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
BMJ (Clinical Research Ed.)|April 21, 2022
Novel treatments in B cell non-Hodgkin's lymphomasYazeed Sawalha, Kami Maddocks
Oncotargets and Therapy|July 2, 2020
Profile of Polatuzumab Vedotin in the Treatment of Patients with Relapsed/Refractory Non-Hodgkin Lymphoma: A Brief Report on the Emerging Clinical DataYazeed Sawalha, Kami Maddocks
Seminars in Oncology|April 5, 2016
Bruton tyrosine kinase inhibition in chronic lymphocytic leukemiaKami Maddocks, Jeffrey A Jones
Current Treatment Options in Oncology|February 1, 2014
Ibrutinib in B-cell LymphomasKami Maddocks, Kristie A Blum
Cancer Treatment and Research|February 7, 2015
Treatment strategies in mantle cell lymphomaKami Maddocks, Kristie A Blum
Current Hematologic Malignancy Reports|September 11, 2016
CD30 and CD30-Targeted Therapies in Hodgkin Lymphoma and Other B cell LymphomasGeetika Bhatt, Kami Maddocks, Beth Christian
The Oncologist|January 17, 2023
Clinical Treatment Guidelines for Tafasitamab Plus Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell LymphomaAdrienne Nedved, Kami Maddocks, Grzegorz S Nowakowski
Clinical Advances in Hematology & Oncology : H&O|June 13, 2019
Bruton tyrosine kinase inhibitors for the treatment of mantle cell lymphoma: review of current evidence and future directionsDavid A Bond, Lapo Alinari, Kami Maddocks
Psychology & Health|March 17, 2016
The relation of illness perceptions to stress, depression, and fatigue in patients with chronic lymphocytic leukaemiaTravis D Westbrook, Kami Maddocks, Barbara L Andersen
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|March 26, 2021
Incorporating Novel Targeted and Immunotherapeutic Agents in Treatment of B-Cell LymphomasHarsh Shah, Deborah Stephens, John Seymour, et al.
Pageof 10